In the preceding three months, 9 analysts have released ratings for Exact Sciences (NASDAQ:EXAS), presenting a wide array of perspectives from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Analysts have set 12-month price targets for Exact Sciences, revealing an average target of $74.0, a high estimate of $85.00, and a low estimate of $67.00. Observing a downward trend, the current average is 12.8% lower than the prior average price target of $84.86. Inter…